GSK Acquires 100 Percent Equity of 35Pharma for USD 950 Million
GSK completes acquisition of 35Pharma, adding HS235, a potential best-in-class therapy for Pulmonary Hypertension.
- Market | 16/04/2026 | By News Bureau
Interviews
Dr. Supriya Shidhaye, Principal, Vivekanand Education Society's College of Pharmacy
As pharmaceutical manufacturing evolves into a technology-driven and globally integrated sector, academic institutions must align closely with industry expectations to build future-ready talent, said Dr. Supriya Shi...
Shivani Wagh, Joint MD, Supriya Lifescience
On the eve of Women’s Day, Shivani Wagh, Joint MD, Supriya Lifescience, speaks to Pharma Industrial India about leadership, global expansion, building inclusive teams, and advancing opportunities for women in ...
Sunil Dubey, Managing Director, SOTAX India
Sunil Dubey, Managing Director, SOTAX India, in an interview with Pharma Industrial India, highlighted the company’s initiatives in India, including affordable quality machinery for small manufacturers, advanc...
Articles
Why Manufacturing Discipline is Becoming a True Differentiator in Generic Pharmaceuticals
Discipline has become the real competitive advantage in generic pharmaceuticals, overtaking scale, speed and low cost as the main drivers of success....
Sustainable Manufacturing for Pharma: Economic and Environmental Impact of Single-Use Systems
Falgun Jani, Business Head – India, Freudenberg Medical, explores the growing role of Single-use Systems (SUS) in enabling sustainable pharmaceutical manufacturing, highlighting their economic advantages, oper...
From Reactive Care to Predictive Pharma: Indian AI Shift by 2026
India’s pharmaceutical industry is transitioning from a reactive, volume-driven model to a predictive, AI-powered ecosystem—highlighting the role of agentic AI, smart manufacturing, resilient supply chai...
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Latest news in...
Drug Discovery & Development
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy